Filing Description Date Filed Sorted Descending Size  
4 shooter, eric m Feb 19, 2010 20.6 KB Add to Briefcase
8-K current report Feb 19, 2010 85.0 KB Add to Briefcase
10-K annual report Feb 18, 2010 2.1 MB Add to Briefcase
8-K current report Feb 16, 2010 60.9 KB Add to Briefcase
SC 13G statement of beneficial ownership Feb 16, 2010 20.4 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 12, 2010 22.1 KB Add to Briefcase
SC 13G statement of beneficial ownership Feb 11, 2010 18.1 KB Add to Briefcase
4 goldberg, murray a Feb 5, 2010 27.5 KB Add to Briefcase
4 roberts, william Feb 4, 2010 28.6 KB Add to Briefcase
4 mccorkle, douglas s Feb 4, 2010 22.5 KB Add to Briefcase
4 kolinski, stuart Feb 4, 2010 26.2 KB Add to Briefcase
4 kolinski, stuart Jan 29, 2010 21.2 KB Add to Briefcase
4 roberts, william Jan 29, 2010 26.4 KB Add to Briefcase
SC 13G statement of beneficial ownership Jan 29, 2010 25.1 KB Add to Briefcase
4 shooter, eric m Jan 22, 2010 20.6 KB Add to Briefcase
4 goldberg, murray a Jan 7, 2010 20.8 KB Add to Briefcase
4 goldberg, murray a Jan 7, 2010 23.5 KB Add to Briefcase
4 gilman, alfred g Jan 6, 2010 31.8 KB Add to Briefcase
4 sing, george l Jan 6, 2010 19.4 KB Add to Briefcase
4 shooter, eric m Jan 6, 2010 21.2 KB Add to Briefcase
Showing 1-20 of 632 Page: 1 2 3 ... 32  Next 20
Add to Briefcase = add filing to Briefcase

The SEC filings provided is for informational purposes only and is not intended for trading purposes. The SEC filings is provided by EDGAR Online, a third party service, and Regeneron Pharmaceuticals, Inc. does not maintain or provide information directly to this service.

Print Print page     Email Email page

Stock Information

NASDAQ:REGN
$24.82   - 0.68
Mar 12, 2010
12:44 PM ET
Quotes delay at least 20min., by eSignal.
Stock price graph
3 Mo.   6 Mo.   1 Yr.

Shareholder Tools

Featured Report